Atea Gross Profit vs Net Income Analysis

AVIR Stock  USD 4.04  0.04  1.00%   
Atea PharmaceuticalsI financial indicator trend analysis is way more than just evaluating Atea PharmaceuticalsInc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Atea PharmaceuticalsInc is a good investment. Please check the relationship between Atea PharmaceuticalsI Gross Profit and its Net Income accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Atea PharmaceuticalsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

Gross Profit vs Net Income

Gross Profit vs Net Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Atea PharmaceuticalsInc Gross Profit account and Net Income. At this time, the significance of the direction appears to have strong relationship.
The correlation between Atea PharmaceuticalsI's Gross Profit and Net Income is 0.65. Overlapping area represents the amount of variation of Gross Profit that can explain the historical movement of Net Income in the same time period over historical financial statements of Atea PharmaceuticalsInc, assuming nothing else is changed. The correlation between historical values of Atea PharmaceuticalsI's Gross Profit and Net Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Gross Profit of Atea PharmaceuticalsInc are associated (or correlated) with its Net Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income has no effect on the direction of Gross Profit i.e., Atea PharmaceuticalsI's Gross Profit and Net Income go up and down completely randomly.

Correlation Coefficient

0.65
Relationship DirectionPositive 
Relationship StrengthSignificant

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Atea PharmaceuticalsInc minus its cost of goods sold. It is profit before Atea PharmaceuticalsI operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Atea PharmaceuticalsInc financial statement analysis. It represents the amount of money remaining after all of Atea PharmaceuticalsInc operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.
Most indicators from Atea PharmaceuticalsI's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Atea PharmaceuticalsInc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Atea PharmaceuticalsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
As of 03/28/2024, Selling General Administrative is likely to drop to about 31.8 M. In addition to that, Tax Provision is likely to drop to about 967.1 K
 2021 2022 2023 2024 (projected)
Interest Income213K11.2M29.2M30.7M
Net Interest Income213K11.2M29.2M30.7M

Atea PharmaceuticalsI fundamental ratios Correlations

0.820.690.980.730.960.55-0.89-0.240.690.890.580.570.41.00.970.13-0.980.90.970.390.980.571.00.970.73
0.820.310.870.830.860.38-0.69-0.030.910.690.420.430.250.820.820.62-0.810.720.820.010.870.410.820.830.8
0.690.310.530.060.50.01-0.72-0.110.010.720.010.02-0.040.690.56-0.29-0.610.390.530.940.530.010.690.560.06
0.980.870.530.840.990.64-0.85-0.240.80.840.670.660.490.980.980.22-0.980.940.990.21.00.650.980.990.83
0.730.830.060.840.840.8-0.46-0.430.930.450.830.840.40.730.790.5-0.820.860.84-0.290.840.830.730.831.0
0.960.860.50.990.840.66-0.79-0.30.840.790.680.680.440.960.990.29-0.970.960.990.170.990.670.960.990.84
0.550.380.010.640.80.66-0.25-0.690.610.251.00.990.540.550.640.03-0.670.830.7-0.280.641.00.550.680.84
-0.89-0.69-0.72-0.85-0.46-0.79-0.25-0.19-0.46-1.0-0.28-0.24-0.54-0.89-0.810.10.81-0.7-0.79-0.5-0.85-0.24-0.89-0.79-0.43
-0.24-0.03-0.11-0.24-0.43-0.3-0.69-0.19-0.240.19-0.68-0.740.19-0.23-0.32-0.090.38-0.43-0.370.01-0.24-0.72-0.24-0.37-0.48
0.690.910.010.80.930.840.61-0.46-0.240.460.650.650.330.690.790.69-0.730.790.8-0.330.80.640.690.790.92
0.890.690.720.840.450.790.25-1.00.190.460.270.230.540.890.81-0.1-0.80.70.780.50.840.240.890.790.43
0.580.420.010.670.830.681.0-0.28-0.680.650.270.990.540.570.660.07-0.690.850.73-0.280.671.00.570.70.86
0.570.430.020.660.840.680.99-0.24-0.740.650.230.990.450.560.660.12-0.690.830.72-0.270.661.00.570.70.87
0.40.25-0.040.490.40.440.54-0.540.190.330.540.540.450.40.43-0.34-0.380.580.45-0.230.490.480.40.410.4
1.00.820.690.980.730.960.55-0.89-0.230.690.890.570.560.40.960.13-0.980.890.970.390.980.561.00.970.72
0.970.820.560.980.790.990.64-0.81-0.320.790.810.660.660.430.960.23-0.970.960.990.230.980.650.961.00.79
0.130.62-0.290.220.50.290.030.1-0.090.69-0.10.070.12-0.340.130.23-0.170.130.22-0.430.220.10.130.230.47
-0.98-0.81-0.61-0.98-0.82-0.97-0.670.810.38-0.73-0.8-0.69-0.69-0.38-0.98-0.97-0.17-0.93-0.98-0.3-0.98-0.68-0.98-0.98-0.81
0.90.720.390.940.860.960.83-0.7-0.430.790.70.850.830.580.890.960.13-0.930.970.050.940.830.90.960.86
0.970.820.530.990.840.990.7-0.79-0.370.80.780.730.720.450.970.990.22-0.980.970.190.990.720.971.00.84
0.390.010.940.2-0.290.17-0.28-0.50.01-0.330.5-0.28-0.27-0.230.390.23-0.43-0.30.050.190.2-0.270.390.23-0.29
0.980.870.531.00.840.990.64-0.85-0.240.80.840.670.660.490.980.980.22-0.980.940.990.20.650.980.990.83
0.570.410.010.650.830.671.0-0.24-0.720.640.241.01.00.480.560.650.1-0.680.830.72-0.270.650.560.690.86
1.00.820.690.980.730.960.55-0.89-0.240.690.890.570.570.41.00.960.13-0.980.90.970.390.980.560.970.72
0.970.830.560.990.830.990.68-0.79-0.370.790.790.70.70.410.971.00.23-0.980.961.00.230.990.690.970.82
0.730.80.060.831.00.840.84-0.43-0.480.920.430.860.870.40.720.790.47-0.810.860.84-0.290.830.860.720.82
Click cells to compare fundamentals

Atea PharmaceuticalsI Account Relationship Matchups

Atea PharmaceuticalsI fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets22.1M863.6M772.9M666.7M595.0M541.8M
Other Current Liab1.9M14.4M52.3M15.2M27.4M20.6M
Total Current Liabilities2.4M315.8M56.9M18.5M32.4M57.0M
Total Stockholder Equity(49.6M)547.8M710.1M640.6M555.2M434.1M
Other Liab95K36K5.9M5.3M6.0M6.3M
Net Tangible Assets(49.6M)547.8M710.1M640.6M736.7M398.8M
Property Plant And Equipment Net41K48K23K4.1M3.1M3.3M
Net Debt(21.7M)(850.1M)(764.2M)(643.6M)(141.4M)(148.5M)
Retained Earnings(54.2M)(65.2M)56.0M(59.9M)(195.8M)(186.0M)
Accounts Payable548K60K4.5M2.6M4.3M2.3M
Cash21.7M850.1M764.4M646.7M143.8M136.6M
Cash And Short Term Investments21.7M850.1M764.4M646.7M578.1M530.8M
Liabilities And Stockholders Equity22.1M863.6M772.9M666.7M595.0M541.8M
Non Current Liabilities Total69.2M36K5.9M7.7M7.4M7.0M
Other Current Assets249K7.5M8.0M14.2M12.3M7.8M
Other Stockholder Equity4.6M612.9M654.0M701.1M750.7M500.0M
Total Liab71.6M315.8M62.8M26.1M39.8M78.3M
Net Invested Capital(49.6M)547.8M710.1M640.6M555.2M434.1M
Property Plant And Equipment Gross41K48K184K4.4M3.8M4.0M
Total Current Assets21.9M863.5M772.4M660.9M590.5M539.7M
Net Working Capital19.5M547.7M715.5M642.4M558.1M461.3M
Property Plant Equipment41K48K23K4.1M4.7M4.9M

Pair Trading with Atea PharmaceuticalsI

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Atea PharmaceuticalsI position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atea PharmaceuticalsI will appreciate offsetting losses from the drop in the long position's value.

Moving together with Atea Stock

  0.69EQ Equillium Financial Report 9th of May 2024 PairCorr

Moving against Atea Stock

  0.89VALN Valneva SE ADR Financial Report 2nd of May 2024 PairCorr
  0.84CALT Calliditas Therapeutics Financial Report 21st of May 2024 PairCorr
  0.8MEIP MEI Pharma Financial Report 9th of May 2024 PairCorr
  0.75PFE Pfizer Inc Sell-off TrendPairCorr
  0.67MGTX MeiraGTx Holdings PLC Financial Report 9th of May 2024 PairCorr
The ability to find closely correlated positions to Atea PharmaceuticalsI could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Atea PharmaceuticalsI when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Atea PharmaceuticalsI - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Atea PharmaceuticalsInc to buy it.
The correlation of Atea PharmaceuticalsI is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Atea PharmaceuticalsI moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Atea PharmaceuticalsInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Atea PharmaceuticalsI can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Atea PharmaceuticalsInc is a strong investment it is important to analyze Atea PharmaceuticalsI's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Atea PharmaceuticalsI's future performance. For an informed investment choice regarding Atea Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Atea PharmaceuticalsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Complementary Tools for Atea Stock analysis

When running Atea PharmaceuticalsI's price analysis, check to measure Atea PharmaceuticalsI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atea PharmaceuticalsI is operating at the current time. Most of Atea PharmaceuticalsI's value examination focuses on studying past and present price action to predict the probability of Atea PharmaceuticalsI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atea PharmaceuticalsI's price. Additionally, you may evaluate how the addition of Atea PharmaceuticalsI to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Is Atea PharmaceuticalsI's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Atea PharmaceuticalsI. If investors know Atea will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Atea PharmaceuticalsI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
2.641
Earnings Share
(1.63)
Revenue Per Share
2.31
Quarterly Revenue Growth
2.952
Return On Assets
(0.12)
The market value of Atea PharmaceuticalsInc is measured differently than its book value, which is the value of Atea that is recorded on the company's balance sheet. Investors also form their own opinion of Atea PharmaceuticalsI's value that differs from its market value or its book value, called intrinsic value, which is Atea PharmaceuticalsI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atea PharmaceuticalsI's market value can be influenced by many factors that don't directly affect Atea PharmaceuticalsI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atea PharmaceuticalsI's value and its price as these two are different measures arrived at by different means. Investors typically determine if Atea PharmaceuticalsI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atea PharmaceuticalsI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.